Dr. Manuel Bello Segura, MD
8435 Clearvista Pl Ste 101, Indianapolis, IN 46256 • +1-558-555-9417
Medical Education: Accredited U.S. Medical School (Class of 2005)
What This Doctor Actually Performs: CMS Medicare Utilization & Indianapolis Percentiles
NPI #1659774669 • CBSA Regional • Endocrinology
Operating out of Indianapolis, IN (8435 Clearvista Pl Ste 101), Endocrinology clinician Dr. Manuel Bello Segura, MD (accredited MD/DO training, 2005) maintains a upper-quartile active clinical volume (80.95th Indianapolis percentile) (83.33th IN percentile; Z-score +0.63σ across 11,991 documented services) with sub-specialty concentration in 20 Active CMS HCPCS Codes.
Procedural volume for Dr. Bello Segura is led by HCPCS 99214 (Complex Endocrine, Thyroid & Metabolic Biomarker Management — 432 annual services, $45–$62 GPCI cash estimate), followed by CPT 95251 (Ambulatory Continuous Glucose Monitoring (CGM) Data Analysis, 216/yr) and CPT 76536 (High-Resolution Thyroid & Parathyroid Neck Ultrasound, 157/yr).
For out-of-network patients contacting +1-558-555-9417, Dr. Bello Segura's practice posts a $209.00 GPCI self-pay consult estimate ($209.00 patient-logged median, 4.57/5 composite reality score over 4 submissions).
Spanning 21 years of clinical practice following 2005 graduation from medical training, Dr. Manuel Bello Segura integrates 20 Active CMS HCPCS Codes diagnostics for Indianapolis metro patients.
Compared against Indianapolis, IN Endocrinology peers
11,991 annual services across 340 beneficiaries
Standard deviations from IN Endocrinology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Complex Endocrine, Thyroid & Metabolic Biomarker Management | 432 | 80.95th | $45 – $62 |
| 95251 | Ambulatory Continuous Glucose Monitoring (CGM) Data Analysis | 216 | 75.95th | $28 – $43 |
| 76536 | High-Resolution Thyroid & Parathyroid Neck Ultrasound | 157 | 81.95th | $55 – $75 |
| 99204 | Comprehensive New Patient Endocrine & Hormone Workup | 118 | 75.95th | $62 – $85 |
| 99215 | High-Complexity Multi-Hormone & Insulin Pump Titration | 59 | 79.95th | $70 – $96 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (20 HCPCS billing breadth) | 11,010 | 80.95th | $45 – $65 |
Are you Dr. Manuel Bello Segura? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Indianapolis, IN:
<a href="https://dotmd.com/doctors/manuel-bello-segura-md-indianapolis-in-1659774669" title="Dr. Manuel Bello Segura, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1659774669.svg" alt="Dr. Manuel Bello Segura Endocrinology Badge" width="280" height="72" /></a>
Dr. Manuel Bello Segura, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Bello Segura National Provider Identifier | NPI #1659774669 (MD) | CMS NPPES Registry (46256) |
| Dr. Bello Segura Indianapolis CMS Volume Rank | 80.95th Pct (11,991 CMS svcs; Z +0.629σ) | CMS Medicare Part B (IN Endocrinology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Indianapolis, IN) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 22 min lobby wait | 4 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.88/5 Listening • 4.80/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Manuel Bello Segura
Other High-Volume Endocrinology Specialists in Indianapolis, IN
Ranked strictly by CMS Medicare volumeDr. Bello Segura Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Indianapolis, IN.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Manuel Bello Segura community threads and patient logs by age, biological sex, dosage, and treatment duration.